Buprenorphine Hcl
Product Images NDC 68071-2915

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hcl (NDC 68071-2915). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2915 3)

Buprenorphine 8mg tablets packaging label from NuCare Pharmaceuticals, Inc. The label indicates a quantity of 30 tablets, each containing 8.64mg of Buprenorphine HCl equivalent to 8mg of Buprenorphine base. It includes the NDC number 68071-2915-3, a schedule III controlled substance symbol, product number R1398030, and warnings to keep out of reach of children and to store at controlled temperature 68-77°F. Additional manufacturing and lot information and a barcode are also present.*

FDA Label Image

Chem-fig (Bup HCl Chem Fig)

Chemical structure diagram of Buprenorphine hydrochloride (Buprenorphine HCl) showing its molecular arrangement with labeled functional groups, including hydroxyl, methoxy, and cyclopropyl components.*

FDA Label Image

Ifu-image (Ifu Image)

Illustration showing a person using a buccal film medication by placing it on the inside of the lower lip. The image demonstrates the proper application method for buccal film dosage forms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.